In Depth 27 Nov 2024
Charcot–Marie–Tooth disease: what’s going on in the clinical field?
In this article, we take a look at the various treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.
About
Having completed a master’s programme in International Journalism from Cardiff University in 2022, I have written about various subjects including culture, politics, social justice, mental health, LGBTQ+ issues and gender. My undergraduate degree in life sciences has equipped me to explore my passion for reporting on health, science and the environment. When I’m not transcribing interviews and fretting about deadlines, I like to spend my time reading, watching movies, and making lousy mixtapes for a potential side career in rap music.
Articles by Roohi Mariam Peter
In Depth 21 Nov 2024
Huntington’s disease: a therapeutic field on a bumpy ride
For years, biotechs have been trying to develop medicines to cure the disease but much to no avail. Now, as clinical studies advance, there is hope.
In Depth 20 Nov 2024
Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024
The hypoparathyroidism treatment space has made quite a buzz this year with a major drug approval, acquisition, and significant advances in clinical trials.
In Depth 13 Nov 2024
Sleep apnea: biotechs snore points in the therapeutic space
Therapeutic strides in biotech are proving to help address different stages of the sleep apnea.
Best in Biotech 7 Nov 2024
Cystic fibrosis: Five biotechs breathing life into the therapeutic space
In this article, we take a look at five biotechs developing potentially transformative medicines to treat this genetic disease.
News and Trends 4 Nov 2024
Top biotech deals of October 2024
Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 29 Oct 2024
GPCR therapies: Eight promising biotechs hacking the cell signaling pathway
In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines.
News and Trends 23 Oct 2024
RNA editing in humans: the race begins with first successful trial
Wave Life Sciences achieves RNA editing in the clinic, crossing a major milestone in the space.
Best in Biotech 22 Oct 2024
Eight nanotechnology companies to watch out for
Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.
Best in Biotech 17 Oct 2024
Top six European biotech entrepreneurs to know in 2024 (according to VCs)
We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market.
In Depth 8 Oct 2024
Top biotech deals of September 2024
There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month.
Best in Biotech 3 Oct 2024
Six biotechs driving progress in Duchenne muscular dystrophy
In this article, we take a look at six clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space.
ADVERTISEMENT
